Neutrophil Gelatinase-Associated Lipocalin and Interleukin-18 in the Prediction of Acute Kidney Injury in Sepsis Patients

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2024 Dec 23

PMID 39712197

Authors

Yajing Liu

Chunming Li

Xiaoya Yang

Shufen Guo

Zhaobo Cui

Hongshan Kang

Zhen Ma

Huiqing Wang

Affiliations

Soon will be listed here.

Abstract

Objective: We assessed the predictive value of blood neutrophil gelatinase-associated lipocalin (NGAL) and interleukin-18 (IL-18) in predicting the onset of acute kidney injury (AKI) in sepsis patients in the intensive care unit (ICU).

Methods: In this retrospective analysis, we examined the medical records of sepsis patients admitted to the ICU. After ICU admission, blood samples were taken at 0 h, 6 h, 12 h, 24 h, and 48 h. Using an enzyme-linked immunosorbent assay, the concentrations of serum creatinine, NGAL, and IL-18 were determined.

Results: This study comprised a total of 197 participants, 104 of whom had AKI and 93 of whom did not. Blood concentrations of NGAL and IL-18 increased prior to serum creatinine levels. Between 6-48 hours after ICU administration, NGAL and IL-18 levels in the AKI group were considerably higher than those in the non-AKI group, and creatinine levels between the two groups were significantly different after 48 hours. Based on receiver operating characteristic (ROC) curve analysis, the area under the curve of NGAL and IL-18 for predicting AKI was 0.781 and 0.883, respectively.

Conclusion: Blood NGAL and IL-18 are potential biomarkers for the early prediction of AKI in sepsis patients in the ICU.

References

Yasuda K, Nakanishi K, Tsutsui H . Interleukin-18 in Health and Disease. Int J Mol Sci. 2019; 20(3). PMC: 6387150. DOI: 10.3390/ijms20030649. View

Xie Y, Huang P, Zhang J, Tian R, Jin W, Xie H . Biomarkers for the diagnosis of sepsis-associated acute kidney injury: systematic review and meta-analysis. Ann Palliat Med. 2021; 10(4):4159-4173. DOI: 10.21037/apm-20-1855. View

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D . Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract. 2008; 108(3):c176-81. DOI: 10.1159/000117814. View

Zarjou A, Agarwal A . Sepsis and acute kidney injury. J Am Soc Nephrol. 2011; 22(6):999-1006. DOI: 10.1681/ASN.2010050484. View

Beker B, Corleto M, Fieiras C, Musso C . Novel acute kidney injury biomarkers: their characteristics, utility and concerns. Int Urol Nephrol. 2018; 50(4):705-713. DOI: 10.1007/s11255-017-1781-x. View

Sung W, Yu H, Tsai Y, Chung P, Lin C, Lee W . The ratio of plasma interleukin-18 is a sensitive biomarker for acute kidney injury after liver transplantation. Transplant Proc. 2014; 46(3):816-7. DOI: 10.1016/j.transproceed.2013.09.055. View

Karvellas C, Farhat M, Sajjad I, Mogensen S, Leung A, Wald R . A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011; 15(1):R72. PMC: 3222005. DOI: 10.1186/cc10061. View

Ricci Z, Ronco C . Pathogenesis of acute kidney injury during sepsis. Curr Drug Targets. 2009; 10(12):1179-83. DOI: 10.2174/138945009789753192. View

10.

Coca S, Yalavarthy R, Concato J, Parikh C . Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2007; 73(9):1008-16. DOI: 10.1038/sj.ki.5002729. View

11.

Suzuki N, Chen N, Millar D, Suzuki S, Horacek T, Hara H . IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses. J Immunol. 2003; 170(8):4031-5. DOI: 10.4049/jimmunol.170.8.4031. View

12.

Skube S, Katz S, Chipman J, Tignanelli C . Acute Kidney Injury and Sepsis. Surg Infect (Larchmt). 2018; 19(2):216-224. DOI: 10.1089/sur.2017.261. View

13.

Seymour C, Liu V, Iwashyna T, Brunkhorst F, Rea T, Scherag A . Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):762-74. PMC: 5433435. DOI: 10.1001/jama.2016.0288. View

14.

Bellomo R, Kellum J, Ronco C, Wald R, Martensson J, Maiden M . Acute kidney injury in sepsis. Intensive Care Med. 2017; 43(6):816-828. DOI: 10.1007/s00134-017-4755-7. View

15.

Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A . Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008; 52(3):595-605. DOI: 10.1053/j.ajkd.2008.01.020. View

16.

Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A . Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009; 54(6):1012-24. DOI: 10.1053/j.ajkd.2009.07.020. View

17.

Devarajan P . Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011; 23(2):194-200. PMC: 3257513. DOI: 10.1097/MOP.0b013e328343f4dd. View

18.

Parikh C, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C . Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006; 70(1):199-203. DOI: 10.1038/sj.ki.5001527. View

19.

Khwaja A . KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4):c179-84. DOI: 10.1159/000339789. View

20.

Alge J, Arthur J . Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol. 2014; 10(1):147-55. PMC: 4284423. DOI: 10.2215/CJN.12191213. View